START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: AIDS and Behavior
Authors: Glenn J. Wagner, Risa Hoffman, Sebastian Linnemayr, Stefan Schneider, Daniel Ramirez, Kyle Gordon, Rachana Seelam, Bonnie Ghosh-Dastidar
Institutions: RAND Corporation, University of California, Los Angeles
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3142679382
